These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 14660590)
1. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes. Nukaga M; Kumar S; Nukaga K; Pratt RF; Knox JR J Biol Chem; 2004 Mar; 279(10):9344-52. PubMed ID: 14660590 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics. Kumar S; Adediran SA; Nukaga M; Pratt RF Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604 [TBL] [Abstract][Full Text] [Related]
3. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling. Huletsky A; Knox JR; Levesque RC J Biol Chem; 1993 Feb; 268(5):3690-7. PubMed ID: 8429044 [TBL] [Abstract][Full Text] [Related]
4. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design. Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888 [TBL] [Abstract][Full Text] [Related]
5. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase. Kim JY; Jung HI; An YJ; Lee JH; Kim SJ; Jeong SH; Lee KJ; Suh PG; Lee HS; Lee SH; Cha SS Mol Microbiol; 2006 May; 60(4):907-16. PubMed ID: 16677302 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation. Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067 [TBL] [Abstract][Full Text] [Related]
7. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion. Crichlow GV; Kuzin AP; Nukaga M; Mayama K; Sawai T; Knox JR Biochemistry; 1999 Aug; 38(32):10256-61. PubMed ID: 10441119 [TBL] [Abstract][Full Text] [Related]
8. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99. Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins. Charnas RL; Then RL Rev Infect Dis; 1988; 10(4):752-60. PubMed ID: 3142012 [TBL] [Abstract][Full Text] [Related]
10. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog. Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611 [TBL] [Abstract][Full Text] [Related]
11. Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. Kuzin AP; Liu H; Kelly JA; Knox JR Biochemistry; 1995 Jul; 34(29):9532-40. PubMed ID: 7626623 [TBL] [Abstract][Full Text] [Related]
12. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime. Hiraoka M; Masuyoshi S; Mitsuhashi S; Tomatsu K; Inoue M J Antibiot (Tokyo); 1988 Jan; 41(1):86-93. PubMed ID: 3279015 [TBL] [Abstract][Full Text] [Related]
13. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase. Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648 [TBL] [Abstract][Full Text] [Related]
14. Amino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase. Zhang Z; Yu Y; Musser JM; Palzkill T J Biol Chem; 2001 Dec; 276(49):46568-74. PubMed ID: 11591698 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance. Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013 [TBL] [Abstract][Full Text] [Related]
16. Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin. Shimamura T; Ibuka A; Fushinobu S; Wakagi T; Ishiguro M; Ishii Y; Matsuzawa H J Biol Chem; 2002 Nov; 277(48):46601-8. PubMed ID: 12221102 [TBL] [Abstract][Full Text] [Related]
17. Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42. Kotsakis SD; Caselli E; Tzouvelekis LS; Petinaki E; Prati F; Miriagou V Antimicrob Agents Chemother; 2013 Feb; 57(2):968-76. PubMed ID: 23229484 [TBL] [Abstract][Full Text] [Related]
18. Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporins. Kotsakis SD; Tzouvelekis LS; Petinaki E; Tzelepi E; Miriagou V Proteins; 2011 Nov; 79(11):3180-92. PubMed ID: 21989938 [TBL] [Abstract][Full Text] [Related]
19. Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme. Nukaga M; Mayama K; Hujer AM; Bonomo RA; Knox JR J Mol Biol; 2003 Apr; 328(1):289-301. PubMed ID: 12684014 [TBL] [Abstract][Full Text] [Related]
20. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa. Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA mBio; 2018 Dec; 9(6):. PubMed ID: 30538183 [No Abstract] [Full Text] [Related] [Next] [New Search]